MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 121.0
(2.72%)
EUR 121.0
(2.72%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 49.12 Billion EUR | 1.23% |
| 2022 | 48.52 Billion EUR | 6.98% |
| 2021 | 45.36 Billion EUR | 8.53% |
| 2020 | 41.79 Billion EUR | -4.6% |
| 2019 | 43.81 Billion EUR | 18.77% |
| 2018 | 36.88 Billion EUR | 3.56% |
| 2017 | 35.62 Billion EUR | -6.88% |
| 2016 | 38.25 Billion EUR | 0.64% |
| 2015 | 38 Billion EUR | 46.12% |
| 2014 | 26.01 Billion EUR | 24.94% |
| 2013 | 20.81 Billion EUR | -3.81% |
| 2012 | 21.64 Billion EUR | -2.16% |
| 2011 | 22.12 Billion EUR | -1.2% |
| 2010 | 22.38 Billion EUR | 33.96% |
| 2009 | 16.71 Billion EUR | 6.83% |
| 2008 | 15.64 Billion EUR | 4.84% |
| 2007 | 14.92 Billion EUR | 84.17% |
| 2006 | 8.1 Billion EUR | 11.29% |
| 2005 | 7.28 Billion EUR | 27.24% |
| 2004 | 5.72 Billion EUR | -18.05% |
| 2003 | 6.98 Billion EUR | -7.04% |
| 2002 | 7.51 Billion EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 49.87 Billion EUR | 0.75% |
| 2024 Q1 | 49.5 Billion EUR | 0.78% |
| 2023 FY | 49.12 Billion EUR | 1.23% |
| 2023 Q4 | 49.12 Billion EUR | -1.57% |
| 2023 Q3 | 49.9 Billion EUR | 2.3% |
| 2023 Q1 | 48.63 Billion EUR | 0.23% |
| 2023 Q2 | 48.78 Billion EUR | 0.3% |
| 2022 Q3 | 50.93 Billion EUR | 4.55% |
| 2022 FY | 48.52 Billion EUR | 6.98% |
| 2022 Q2 | 48.71 Billion EUR | 5.37% |
| 2022 Q1 | 46.23 Billion EUR | 1.92% |
| 2022 Q4 | 48.52 Billion EUR | -4.73% |
| 2021 Q2 | 43.14 Billion EUR | -1.7% |
| 2021 Q4 | 45.36 Billion EUR | 3.48% |
| 2021 Q3 | 43.83 Billion EUR | 1.6% |
| 2021 FY | 45.36 Billion EUR | 8.53% |
| 2021 Q1 | 43.89 Billion EUR | 5.01% |
| 2020 Q2 | 43.82 Billion EUR | -2.06% |
| 2020 Q1 | 44.74 Billion EUR | 2.13% |
| 2020 Q3 | 43.23 Billion EUR | -1.35% |
| 2020 Q4 | 41.79 Billion EUR | -3.32% |
| 2020 FY | 41.79 Billion EUR | -4.6% |
| 2019 Q4 | 43.81 Billion EUR | 4.15% |
| 2019 Q1 | 38.71 Billion EUR | 4.96% |
| 2019 Q2 | 39.56 Billion EUR | 2.2% |
| 2019 Q3 | 42.06 Billion EUR | 6.32% |
| 2019 FY | 43.81 Billion EUR | 18.77% |
| 2018 FY | 36.88 Billion EUR | 3.56% |
| 2018 Q1 | 35.17 Billion EUR | -1.25% |
| 2018 Q2 | 35.82 Billion EUR | 1.86% |
| 2018 Q3 | 35.74 Billion EUR | -0.25% |
| 2018 Q4 | 36.88 Billion EUR | 3.21% |
| 2017 Q1 | 38.35 Billion EUR | 0.26% |
| 2017 Q4 | 35.62 Billion EUR | -0.58% |
| 2017 Q3 | 35.83 Billion EUR | -2.57% |
| 2017 Q2 | 36.77 Billion EUR | -4.11% |
| 2017 FY | 35.62 Billion EUR | -6.88% |
| 2016 Q4 | 38.25 Billion EUR | 4.11% |
| 2016 Q3 | 36.74 Billion EUR | -0.77% |
| 2016 Q2 | 37.02 Billion EUR | -0.4% |
| 2016 FY | 38.25 Billion EUR | 0.64% |
| 2016 Q1 | 37.17 Billion EUR | -2.19% |
| 2015 Q2 | 29.8 Billion EUR | -3.11% |
| 2015 Q3 | 32.26 Billion EUR | 8.26% |
| 2015 Q1 | 30.76 Billion EUR | 18.27% |
| 2015 FY | 38 Billion EUR | 46.12% |
| 2015 Q4 | 38 Billion EUR | 17.8% |
| 2014 FY | 26.01 Billion EUR | 24.94% |
| 2014 Q2 | 21.47 Billion EUR | 2.23% |
| 2014 Q1 | 21 Billion EUR | 0.91% |
| 2014 Q4 | 26.01 Billion EUR | 14.47% |
| 2014 Q3 | 22.72 Billion EUR | 5.8% |
| 2013 Q1 | 21.95 Billion EUR | 1.43% |
| 2013 FY | 20.81 Billion EUR | -3.81% |
| 2013 Q4 | 20.81 Billion EUR | -2.38% |
| 2013 Q3 | 21.32 Billion EUR | -2.13% |
| 2013 Q2 | 21.79 Billion EUR | -0.75% |
| 2012 Q3 | 22.27 Billion EUR | 1.72% |
| 2012 Q4 | 21.64 Billion EUR | -2.83% |
| 2012 FY | 21.64 Billion EUR | -2.16% |
| 2012 Q1 | 21.49 Billion EUR | -2.85% |
| 2012 Q2 | 21.89 Billion EUR | 1.89% |
| 2011 Q3 | 22.39 Billion EUR | 2.3% |
| 2011 FY | 22.12 Billion EUR | -1.2% |
| 2011 Q1 | 22.21 Billion EUR | -0.76% |
| 2011 Q2 | 21.89 Billion EUR | -1.48% |
| 2011 Q4 | 22.12 Billion EUR | -1.22% |
| 2010 Q2 | 22.28 Billion EUR | 8.25% |
| 2010 Q1 | 20.58 Billion EUR | 23.16% |
| 2010 FY | 22.38 Billion EUR | 33.96% |
| 2010 Q4 | 22.38 Billion EUR | -2.7% |
| 2010 Q3 | 23 Billion EUR | 3.26% |
| 2009 FY | 16.71 Billion EUR | 6.83% |
| 2009 Q4 | 16.71 Billion EUR | 0.0% |
| 2008 FY | 15.64 Billion EUR | 4.84% |
| 2007 FY | 14.92 Billion EUR | 84.17% |
| 2006 FY | 8.1 Billion EUR | 11.29% |
| 2005 FY | 7.28 Billion EUR | 27.24% |
| 2004 FY | 5.72 Billion EUR | -18.05% |
| 2003 FY | 6.98 Billion EUR | -7.04% |
| 2002 FY | 7.51 Billion EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| MPH Health Care AG | 266.35 Million EUR | -18342.467% |
| Apontis Pharma AG | 57.5 Million EUR | -85329.565% |
| Dermapharm Holding SE | 2.18 Billion EUR | -2149.686% |
| Evotec SE | 2.29 Billion EUR | -2036.619% |
| PharmaSGP Holding SE | 131.29 Million EUR | -37312.318% |
| SynBiotic SE | 34.91 Million EUR | -140577.496% |